Atlas Trials

Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus

Clinical trial NCT01447927 · COMPLETED

Trial details

NCT number
NCT01447927
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Barrett EsophagusEsophageal Cancer
Start date
2012-06-01
Primary completion
2013-05-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.